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Abstract a-Tocopherol transfer protein (aTTP), a product of 
the gene which causes familial isolated vitamin E deficiency, 
plays an important role in determining the plasma vitamin E 
level. We examined the structural characteristics of vitamin E 
analogs required for recognition by aTTP. Ligand specificity 
was assessed by evaluating the competition of non-labeled 
vitamin E analogs and a-[3H|tocopherol for transfer between 
membranes in vitro. Relative affinities (/J/?/?-a-tocopher-
ol = 100%) calculated from the degree of competition were as 
follows: ß-tocopherol, 38%; y-tocopherol, 9%; 5-tocopherol, 
2%; a-tocopherol acetate, 2%; a-tocopherol quinone, 2%; SRR-
a-tocopherol, 11%; a-tocotrienol, 12%; trolox, 9%. Interest-
ingly, there was a linear relationship between the relative affinity 
and the known biological activity obtained from the rat 
résorption-gestation assay. From these observations, we conclude 
that the affinity of vitamin E analogs for aTTP is one of the 
critical determinants of their biological activity. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Vitamin E is a fat-soluble antioxidant that prevents lipid 
oxidation in biological membranes[l] . Vitamin E occurs in 
nature in eight different forms: a-, ß-, y- and 5-tocopherols 
(which have a chromanol ring and phytyl tail and differ in the 
number and position of methyl groups on the ring) and a-, ß-, 
y- and 8-tocotrienols (which have unsaturated tails). Synthetic 
a-tocopherol , sold as a vitamin E supplement, contains stere-
oisomers arising from different configurations of the phytyl 
tail. It has long been recognized that the antioxidant activities 
of the various forms of vitamin E are usually unrelated to 
their biological activities [2,3]. 
a-Tocopherol transfer protein (aTTP) , which binds this 
vitamin and enhances its transfer between membranes, is 
present in the liver cytosol of animals, including rats [4] and 
humans [5]. Recently, we have cloned the gene encoding 
a T T P from rats and humans and demonstrated it to be the 
causative gene for familial isolated vitamin E deficiency [6,7]. 
Patients affected by this disease have remarkably low plasma 
levels of a-tocopherol [8,9]. These findings established liver 
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a T T P as a critical factor in determining the plasma a-toco-
pherol level. Previously, we showed that a T T P binds to a-
tocopherol in preference to other tocopherol analogs [4,10]. 
However, detailed studies have not fully classified the struc-
tural requirements needed for recognition by a T T P . In the 
present investigation, we analyzed ligand specificity for 
a T T P in more detail and demonstrated that the relative affin-
ity of tocopherol analogs for a T T P correlates well with their 
biological activity. 
2. Materials and methods 
2.1. Materials 
Egg-yolk phosphatidylcholine was prepared by chromatography on 
neutral aluminium oxide and silica acid. D-a-[3H]tocopherol acetate 
(11.3 Ci/mmol) was purchased from Amersham (Buckinghamshire, 
UK). Glycerol tri[carboxyl-14C]oleate (112 mCi/mmol) was purchased 
from NEN (Dreieich, Germany). RRR-a-, ß-, y- and 8-tocopherol, a-
tocotrienol, RRR-a-tocophero\ acetate and 2-araèo-a-tocopherol ace-
tate were kindly donated by Eisai Co. (Tokyo, Japan). SRR-a-toco-
pherol was purified from 2-amfto-a-tocopherol acetate as described 
previously [11]. 
2.1.1. Purification of D-a-[s HJtocopherol from D-a-[3Hj'tocopherol 
acetate. The procedure was based on the experiments of Syvaoja and 
Salminen [12]. D-a-[3H]Tocopherol acetate was saponified and the 
resulting d-a-[3H]tocopherol was extracted with hexane and purified 
by silica gel G thin layer chromatography. 
2.2. Preparation of donor liposomes 
Liposomes composed of egg-yolk phosphatidylcholine, dicetylphos-
phate and butylhydroxytoluene (molar ratio 10:1:0.5)with traces of a-
[3H]tocopherol (4.0X106 dpm) and glycerol tri[14C]oleate (5.5X105 
dpm) as non-exchangeable markers were prepared as described pre-
viously [10]. 
2.3. Preparation of an acceptor membrane fraction from rat liver 
A crude membrane fraction was prepared from male Sprague-Daw-
ley rat (350-500 g) livers according to a previously described proce-
dure [4]. 
2.4. Determination of the transfer of a-tocopherol from the liposomes 
to the crude membrane fraction 
The procedure was based on the experiments of Bloj and Zilversmit 
[13]. A given amount of liposomes (0.07 njnol phospholipid/tube) was 
incubated with the membranes (0.05 mg protein) in the presence or 
absence of purified aTTP in 1 ml of buffer A (0.25 M sucrose, 1 mM 
EDTA, 10 mM Tris-HCl, pH 7.4). After incubation at 37°C for 30 
min, the membranes were precipitated by centrifugation at 15000Xg 
for 15 min, and the radioactivity in 0.8 ml of supernatant was 
counted. Using this procedure, approximately 90% of the liposomes 
were recovered in the supernatant. The transfer of a-[3H]tocopherol 
from the liposomes to mitochondria was calculated from the following 
equation : 
Abbreviations: aTTP, a-tocopherol transfer protein 
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(l—3!!/1 C content of liposomes after incubation/ H/ C 
content of liposomes before incubation) X100% (1) 
2.5. Purification of uTTP 
aTTP was purified from male Sprague-Dawley rat (350-500 g) liv-
ers as described previously [4]. The purified protein was frozen in 
liquid nitrogen and stored at — 80°C until use. Protein concentrations 
were determined by the Lowry method [14]. 
2.6. Determination of the apparent IC^o of various tocopherol analogs 
KM and Fmax were estimated according to the following equation: 
Vmaxx[S}/KM + [S} (2) 
in which vc is the apparent transfer rate of a-[3H]tocopherol in the 
absence of another tocopherol analog, [S] is the concentration of a-
[3H]tocopherol, ( ^ is the maximum transfer rate of a-
[3H]tocopherol and KM is the Michaelis constant. Since [5] is much 
smaller than KM, Eq. 2 becomes: 
v c = VmNX[S\IKM 
Solving for VmaxIKu in Eq. 3: 
* W * M = Vc/[5] 
(3) 
(4) 
As the inhibition of a-[3H]tocopherol transport by the various toco-
pherol analogs was competitive, the apparent IC50 value was deter-
mined from the following Michaelis-Menten equation: 
Vi — ' m a x 
X[S]/KM(l + [I]/ICb0) + [S] 
(5) 
in which Vi is the concentration of a-[3H]tocopherol and [I\ is the 
concentration of the other tocopherol analogs. Since [5] is much 
smaller than KM, Eq. 5 becomes: 
Vi = Kmax X [S]/KM(1 + [/]/IC50) (6) 
Substituting for V^^/KM in Eq. 6: 
^ = vc/ l + [71/ICso (7) 
Solving for IC50 in Eq. 7: 
IC50 = [/]/(vc/v;-l) (8) 
The relative affinity was then calculated using the following equation: 
Relative affinity = 1/IC50 (9) 
3. Results and discussion 
Under the conditions used for the determination of a T T P 
activity, the reaction was linearly dependent on the purified 
a T T P protein concentration up to 40 ng (Fig. 1). The reaction 
Table 1 
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Fig. 1. Dose-response relationship of aTTP and a-tocopherol trans-
fer activity. Liposomes were incubated with membranes at 37°C for 
30 min in the presence of various amounts of purified aTTP iso-
form (I). Each point denotes the mean 1 SE of three experiments. 
The membranes were then precipitated by centrifugation and the ra-
dioactivity of aliquots of supernatant was measured. The percentage 
of a-tocopherol transferred was calculated as described in Section 2. 
proceeded linearly for up to 30 min at 37°C (data not shown). 
A variety of vitamin E analogs were tested for their ability to 
compete for transfer between membranes. First, liposomes 
containing varying amounts of non-labeled a-tocopherol 
were subjected to the a T T P assay. As shown in Fig. 2, the 
transfer of radioactive a-tocopherol was progressively reduced 
by increasing concentrations of non-labeled a-tocopherol , in-
Relative affinities of various tocopherol analogs were calculated from 
Eq. 9 as described in Section 2, taking the relative affinity of a-toco-
pherol as 100. Each point denotes the mean ± SE of three experiments. 
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Fig. 2. Inhibition of aTTP isoform (I)-mediated a-[3H]tocopherol 
transfer by various amounts of unlabeled a-tocopherol. Liposomes 
composed of egg yolk phosphatidylcholine, bis(hexadecanyl)-phos-
phate and various amounts of unlabeled a-tocopherol with traces of 
radioactive a-tocopherol (5.7 X 104 dpm) were incubated with mito-
chondria at 37°C for 30 min in the presence of 40 ng purified 
aTTP. Each point denotes the mean 1 SE of three experiments. 
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Fig. 3. Effect of the incorporation of unlabeled tocopherol analogs 
into liposomes on the transfer of a-[3H]tocopherol. Liposomes com-
posed of egg yolk phosphatidylcholine, bis(hexadecanyl)-phosphate 
and chromanol (A) or side chain (B) analogs of a-tocopherol (mo-
lar ratio 10:1:0.16, 0.07 umol phospholipid/tube) with traces of ra-
dioactive a-tocopherol (5.7 X104 dpm) were incubated with mem-
branes at 37°C for 30 min in the presence of 40 ng purified aTTP. 
Each point denotes the means ± SE of three experiments. 
dicating that the amount of radioactive tocopherol, which 
acted as a substrate for aTTP, in the donor liposomes was 
saturated under the present assay conditions. 
Initial studies examined the inhibitory effects of vitamin E 
analogs with differing numbers of methyl groups on their 
chromanol rings or those without a free hydroxyl group on 
the transfer of radioactive a-tocopherol. For this, a 50-fold 
excess of each analog was added to the donor liposomes in 
addition to radioactive a-tocopherol, and the effect on the 
transfer of radioactive a-tocopherol was examined. Under 
these conditions, a-, ß-, y- and 8-tocopherols inhibited the 
activity by 0.9%, 2.2%, 6.7%, 15.8%, respectively (Fig. 3). 
The following values were obtained from Eq. 9 (with RRR-
a-tocopherol = 100%): ß-tocopherol, 38.1%; y-tocopherol, 
8.9%; ô-tocopherol, 1.6% (Table 1). These data suggest that 
all three methyl groups are important for recognition by 
aTTP, but that the methyl group at position 5 on the chro-
manol ring is especially important in the light of the difference 
in affinity between ß- and y-tocopherols. a-Tocopherol acetate 
and a-tocopheryl quinone, both of which have no free hy-
droxyl group, are poor substrates for aTTP (relative affinities 
are about 2%). 
The influence of the side-chain on the transfer was analyzed 
by a second series of investigations. For this, we used SRR-a-
tocopherol, a stereoisomer of J?7?7?-a-tocopherol, a-tocotrie-
nol, which has an unsaturated tail, and trolox, which is a-
tocopherol with a carboxyl group instead of the phytyl tail. It 
was found that these analogs had approximately the same 
potency to inhibit aTTP, the relative affinity for aTTP being 
calculated as approximately 10% (Table 1). These data indi-
cate that although aTTP also recognizes the phytyl chain 
structure and its orientation, a tocopherol analog without a 
side chain still possesses 10% affinity for aTTP compared with 
one containing the phytyl chain. 
Considerable efforts have been made to determine the bio-
logical activity of the various forms of vitamin E [3,15-17]. 
The biological activity of a-tocopherol and its analogs has 
been determined using various physiological, biochemical 
and chemical tests. Among the functional tests, the rat résorp-
tion-gestation test and the in vivo hemolysis test have been 
widely accepted. Here, the known biological activity of each 
analogs obtained using the résorption-gestation test [18] was 
plotted against the relative affinity for aTTP. Interestingly, as 
shown in Fig. 4, there was a good linear relationship between 
relative affinity and biological activity. 
It has long been recognized that the antioxidant activities of 
the various forms of vitamin E are not consistent with their 
biological activities. From these observations, it has been hy-
pothesized a-tocopherol may have a specific function other 
than antioxidant activity. In fact, a-tocopherol is known to 
be a potent inhibitor of protein kinase C [19] or phospholipase 
A2 [20], although its physiological significance is not yet clear. 
Catignani and Bieri first noted that the biological activities of 
the various forms of vitamin E were similar to their ability to 
compete for binding to the tocopherol binding protein [21]. 
The present data strongly support this notion. 
The function of aTTP is to incorporate vitamin E taken up 
by liver cells into very low-density lipoproteins. The tissues 
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Fig. 4. Correlation of the biological activities of tocopherol analogs 
with their affinities for aTTP. Relative affinities of ß- (o), y- (□) 
and 8-tocopherol ( A ) and a-tocotrienol (X) were calculated from 
Eq. 9 as described in Section 2, taking the relative affinity of a-to-
copherol (•) as 100. Each point denotes the meant SE of three ex-
periments. Biological activities are those determined by Leth and 
Sondergaard [18]. 
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mechanisms that depend upon the normal metabolism of lip-
oproteins. The biological activity of vitamin E is thus depend-
ent upon its delivery to tissues, and reductions in the binding 
capacity or affinity of aTTP will limit the secretion of the 
various forms of vitamin E into lipoproteins and the subse-
quent delivery of vitamin E by these lipoproteins to tissues. 
The biological activity of various vitamin E analogs may be 
determined by a number of factors including their chemical 
antioxidant activities and physicochemical natures. From the 
result of this study, we propose that the affinity of vitamin E 
analogs for aTTP, which may in turn determine their plasma 
levels, is one of the major determinants of their biological 
activity. 
References 
[1] M.G. Traber, Free Radie. Biol. Med. 16 (1994) 229-239. 
[2] Mukai, K. (1993) in: L. Packer and J. Fuchs (eds.) Vitamin E in 
health and disease. Marcel Dekker, New York, pp. 97-119. 
[3] J. Bunyan, D. McHale, J. Green, Br. J. Nutr. 15 (1961) 253-257. 
[4] Y. Sato, K. Hagiwara, H. Arai, K. Inoue, FEBS Lett. 288 (1991) 
41-45. 
[5] M. Arita, Y. Sato, A. Miyata, T. Tanabe, H. Arai, K. Inoue, 
Biochem. J. 306 (1995) 437-443. 
[6] K. Ouauchi, M. Arita, HJ. Kayden, F. Hentati, M.B. Hamida, 
A. Hosomi et al.lFEBS Letters 409 (1997) 105-108 
R. Sokol, H. Arai, K. Inoue, J.L. Mandel, M. Koenig, Nature 
Genet. 9 (1995) 141-145. 
[7] T. Gotoda, M. Arita, H. Arai, K. Inoue, T. Yokota, Y. Fukuo, 
Y. Yazaki, N. Yamada, N. Engl. J. Med. 333 (1995) 1313-1318. 
[8] D.A. Krendel, J.M. Gilchrest, A.O. Johnson, E.H. Bossen, Neu-
rology 37 (1987) 538-540. 
[9] T. Yokota, Y. Mada, T. Furukawa, H. Tsukagoshi, T. Uchihara, 
S. Watabiki, Ann. Neurol. 22 (1987) 84-87. 
[10] H. Mowri, Y. Nakagawa, K. Inoue, S. Nojima, Eur. J. Biochem. 
117 (1981) 537-542. 
[11] Y. Kiyose, R. Muramatsu, T. Ueda, O. Igarashi, Biosci. Biotech. 
Biochem. 59 (1995) 791-795. 
[12] E.L. Syvaoja, K. Salminen, JAOCS 62 (1985) 1245-1248. 
[13] R. Bloj, D.B. Zilversmit, J. Biol. Chem. 252 (1977) 1613-1619. 
[14] O.H. Lowry, N.J. Rosebrough, A.L. Farr, R.J. Randall, J. Biol. 
Chem. 193 (1951) 265-275. 
[15] H. Weiser, M. Vechi, Int. J. Vit. Nutr. Res. 51 (1981) 100-113. 
[16] H. Weiser, M. Vechi, M. Schlacchter, Int. J. Vit. Nutr. Res. 55 
(1985) 149-158. 
[17] H. Weiser, M. Vechi, M. Schlacchter, Int. J. Vit. Nutr. Res. 56 
(1986) 45-56. 
[18] T. Leth, H. Sonderbaard, J. Nutr. 107 (1977) 2236-2243. 
[19] C.W. Mahoney, A. Azzi, Biochem. Biophys. Res. Commun. 154 
(1988) 694-697. 
[20] A.P. Pentland, A.R. Morrison, S.C. Jacobs, L.H. Luciann, J.S. 
Herbert, L. Packer, J. Biol. Chem. 267 (1992) 15578-15584. 
[21] G.L. Catignani, J.G. Bieri, Biochim. Biophys. Acta 497 (1977) 
349-357. 
